The Global Cannabis Partnership is a collaboration of leaders in the government-sanctioned adult-use recreational cannabis industry. With representation from government, private-sector and affiliate organizations, the Partnership works to create international standards for the safe and responsible production, distribution and consumption of legal recreational cannabis
The Global Cannabis Partnership (GCP) is pleased to announce the addition of seven new Members as it continues to grow internationally, bringing its total membership number to 31.
The GCP welcomes Cannvas MedTech Inc., Compass Cannabis Clinic / Starbuds Canada, Constance Therapeutics, MediPharm Labs Corp., Nutrasource Pharmaceutical & Neutraceutical Services, StrainprintTM Technologies Ltd. and YSS by Solo.
“There’s a growing interest in the GCP as more stakeholders recognize the importance and value of working together on industry-wide CSR policies and programs,” says Kim Wilson, Executive Director. “At a time when everyone is learning as they go, and as this nascent industry develops around the world, now is the time to work collaboratively, share insights and knowledge, and set the bar for socially responsible practices.”
The Member category is open to government agencies, licensed producers, national associations, industry partners and community groups from the global cannabis industry. Neither advocacy nor a lobby group, the GCP represents a cross-section of organizations that play – or will play – a role in the legal, adult-use recreational cannabis supply chain. The GCP mirrors successful initiatives in other industry sectors, such as alcohol, gaming, pharmaceuticals and forestry.
The GCP is working with two of its Founding Members, PwC Canada and McCarthy Tétrault, to establish itself as a non-profit legal entity, and finalize a governance structure led by a board of directors. The development of the Responsible Cannabis Framework, a worldwide social responsibility standard, is near completion and will be launched in 2019.
